𝔖 Bobbio Scriptorium
✦   LIBER   ✦

BLOOD SCREENING FOR NON-A, NON-B HEPATITIS BY HEPATITIS C VIRUS ANTIBODY ASSAY

✍ Scribed by T. KATAYAMA; S. KIKUCHI; Y. TANAKA; I. SAITO; T. MIYAMURA; Q.-L. CHOO; M. HOUGHTON; G. KUO

Book ID
114438989
Publisher
Elsevier Science
Year
1990
Tongue
English
Weight
228 KB
Volume
30
Category
Article
ISSN
0372-1248

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Improved serodiagnosis of non-A, non-B h
Improved serodiagnosis of non-A, non-B hepatitis by an assay detecting antibody to hepatitis C virus core antigen
✍ Tohru Katayama; Toshio Mazda; Shu Kikuchi; Shizuko Harada; Yoshiharu Matsuura; J πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 493 KB πŸ‘ 1 views

We examined sequential serum samples from 12 patients with well-characterized posttransfusion non-A, non-B hepatitis who had an acute, resolving self-limited type of clinical course for the presence of antibody to the hepatitis C virus nucleocapsid (core) protein (p22) expressed by a recombinant bac

Recombinant immunoblot assay for hepatit
Recombinant immunoblot assay for hepatitis C antibody in patients with posttransfusion non-A, non-B hepatitis
✍ Jin-Town Wang; Dr. Teh-Hong Wang; Jaw-Town Lin; Jin-Chuan Sheu; Sy-Ming Lin; Jue πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 593 KB

## Abstract In a prospective study of 287 patients who received blood transfusion, 26 who were found positive for hepatitis C antibody (anti‐HCV) by an enzyme‐linked immunosorbant assay (ELISA) were studied by a recombinant immunoblot assay (RIBA). Nineteen of the 26 patients had posttransfusion no

Interrelationship of blood transfusion,
Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus
✍ Kendo Kiyosawa; Takeshi Sodeyama; Eiji Tanaka; Yukio Gibo; Kaname Yoshizawa; Yos πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 523 KB

To clarify the relationship between hepatitis C virus infection and the development of hepatocellular carcinoma as sequelae of non-A, non-B posttransfusion hepatitis, 231 patients with chronic non-A, non-B hepatitis (96 with chronic hepatitis, 81 with cirrhosis and 64 with hepatocellular carcinoma)